SFM
INZY
Sphera Funds Management’s Inozyme Pharma INZY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,191,140
| Closed | -$1.08M | – | 110 |
|
|
2025
Q1 | $1.08M | Hold |
1,191,140
| – | – | 0.25% | 85 |
|
|
2024
Q4 | $3.3M | Hold |
1,191,140
| – | – | 0.6% | 63 |
|
|
2024
Q3 | $6.23M | Sell |
1,191,140
-271,584
| -19% | -$1.42M | 0.99% | 35 |
|
|
2024
Q2 | $6.52M | Buy |
1,462,724
+89,817
| +7% | +$401K | 0.89% | 34 |
|
|
2024
Q1 | $10.5M | Sell |
1,372,907
-190,000
| -12% | -$1.46M | 1.48% | 23 |
|
|
2023
Q4 | $6.66M | Buy |
1,562,907
+328,000
| +27% | +$1.4M | 1.07% | 33 |
|
|
2023
Q3 | $5.19M | Buy |
1,234,907
+102,940
| +9% | +$432K | 0.94% | 33 |
|
|
2023
Q2 | $6.31M | Sell |
1,131,967
-649,891
| -36% | -$3.62M | 0.98% | 30 |
|
|
2023
Q1 | $10.2M | Buy |
1,781,858
+156,800
| +10% | +$898K | 1.71% | 13 |
|
|
2022
Q4 | $1.71M | Buy |
1,625,058
+450,000
| +38% | +$473K | 0.37% | 39 |
|
|
2022
Q3 | $3.15M | Buy |
1,175,058
+9,458
| +0.8% | +$25.3K | 0.44% | 42 |
|
|
2022
Q2 | $5.56M | Buy |
+1,165,600
| New | +$5.56M | 0.59% | 24 |
|
|
2020
Q4 | – | Sell |
-196,411
| Closed | -$5.16M | – | 114 |
|
|
2020
Q3 | $5.16M | Buy |
+196,411
| New | +$5.16M | 0.51% | 54 |
|